NeuroVive Pharmaceutical and A1M Pharma initiate research collaboration

30th March 2014

NeuroVive Pharmaceutical AB (publ) (STO:NVP) and A1M Pharma AB (publ)  have announced that the two companies are initiating a research collaboration in mitochondrial medicine. The partnership is governed by  a collaboration agreement signed on 21 March 2014.

Initially, the purpose of the collaboration is to utilize the  companies’ complementary scientific platforms within the framework of  ongoing research projects. The companies will evaluate results achieved to date, then explore the potential for a closer collaboration focusing   on bringing products to market in a time-efficient manner.

Read full article at source www.businesswire.com

 


Leave a Reply

Your email address will not be published.

19 − = 11

« back to posts